ABL Bio

본문영역 바로가기

Investors & Media

News

HomeInvestors & MediaNews

[YTN사이언스] 이중 항체 기술로 암 치료제를 개발하는 기업: 2022-08-30ablbio; https://science.ytn.co.kr/hotclip/view.php?s_mcd=1213&key=202208191636054423

list

PREV: ABL Bio Enters Global Collaboration and License Agreement with SANOFI to Advance ABL301 for the Treatment of Parkinson’s Disease

NEXT